Introduction
Leading pharmaceutical company has acquired full ownership of a healthcare subsidiary, strengthening its portfolio in medicaments and healthcare products, with a strategic cash acquisition valued at Rs. 7,249 million.
Also Read: Textile stocks with price to book value of less than 1 to look out for
Share price movement of Emcure Pharmaceuticals
On October 6, 2025, Emcure Pharmaceuticals Ltd opened at ₹1,342.05, up 0.15% from its previous close of ₹1,340.30. The stock reached a high of ₹1,448.00 and a low of ₹1,342.05. By 1:00 PM, it traded at ₹1,435.55, a 7.11% increase, with a market cap of ₹27,204.87 crore.
Emcure Completes Acquisition of Zuventus Healthcare
Emcure Pharmaceuticals Limited has completed the acquisition of 4,095,180 equity shares, representing 20.42% of Zuventus Healthcare Limited. This makes Zuventus a wholly-owned subsidiary of Emcure. The total consideration paid was Rs. 7,249 million.
Zuventus Healthcare Limited operates in the pharmaceutical sector, dealing with all types of medicaments and healthcare products. The company reported a turnover of Rs. 10,798.99 million and a PAT of Rs. 1,347.82 million for FY2024-25.
Prior to acquisition, Emcure held 79.58% in Zuventus. The transaction was completed in cash without requiring regulatory approvals, and the shares were credited to Emcure’s demat account after due procedures.
Stock performance of Emcure Pharmaceuticals for Period of 1 week, 6 months, and 1 year
Emcure Pharmaceuticals Ltd delivered a 5.35% return over the past week, it gained 48.0% in the past six months. The stock declined by 6.10% over the past year.
Also Read: Chemical stock with high dividend yield to add to your watchlist
Shareholding pattern of Emcure Pharmaceuticals
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
| Promoter | 78% | 77.90% | 77.90% |
| FII | 2.90% | 3.10% | 3.10% |
| DII | 2.80% | 3.40% | 3.90% |
| Public | 16.40% | 15.60% | 15.20% |
About Emcure Pharmaceuticals
Emcure Pharmaceuticals Ltd (NSE: EMCURE) develops, manufactures, and markets a wide range of pharmaceutical and biopharmaceutical products globally, covering multiple therapeutic areas with over 350 brands across 70+ countries.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
Q: Why is Emcure Pharmaceuticals Ltd share price going up today?
A: Emcure Pharmaceuticals Ltd has acquired 20.42% stake in Zuventus Healthcare, making it a wholly-owned subsidiary, boosting its healthcare sector presence.
Q: What does Emcure Pharmaceuticals Ltd specialize in?
A: Emcure Pharmaceuticals Ltd specializes in manufacturing and marketing pharmaceutical and biopharmaceutical products across multiple therapeutic areas globally.
Q: What is the market capitalization of Emcure Pharmaceuticals Ltd?
A: The market capitalization of Emcure Pharmaceuticals Ltd is ₹27,204.87 crore as of October 6, 2025.
